E31804
Ethyl 5-hydroxy-2-methylindole-3-carboxylate
97%
Synonym(s):
NSC 405600
Sign Into View Organizational & Contract Pricing
Select a Size
About This Item
Empirical Formula (Hill Notation):
C12H13NO3
CAS Number:
Molecular Weight:
219.24
EC Number:
MDL number:
UNSPSC Code:
12352100
PubChem Substance ID:
NACRES:
NA.22
Assay
97%
mp
205-208 °C (lit.)
SMILES string
CCOC(=O)c1c(C)[nH]c2ccc(O)cc12
InChI
1S/C12H13NO3/c1-3-16-12(15)11-7(2)13-10-5-4-8(14)6-9(10)11/h4-6,13-14H,3H2,1-2H3
InChI key
BSNHKSUAAMJXBB-UHFFFAOYSA-N
Application
Reactant for preparation of:
- Potential anti-inflammatory and analgesic agents
- Histamine-3 receptor inverse agonists for the treatment of obesity
- Tubulin Polymerization Inhibitors
- 4,7-dioxoindole-3-methyl prodrugs
- Antagonists at M4 muscarinic receptors
Storage Class Code
11 - Combustible Solids
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Personal Protective Equipment
dust mask type N95 (US), Eyeshields, Gloves
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Pascale David Pierson et al.
Journal of medicinal chemistry, 52(13), 3855-3868 (2009-05-22)
Obesity is a major risk factor in the development of conditions such as hypertension, hyperglycemia, dyslipidemia, coronary artery disease, and cancer. Several pieces of evidence across different species, including primates, underscore the implication of the histamine 3 receptor (H(3)R) in
Thomas M Böhme et al.
Journal of medicinal chemistry, 45(14), 3094-3102 (2002-06-28)
Previously, we reported on PD 102807 (41) as being the most selective synthetic M(4) muscarinic antagonist identified to date. Synthesized analogues of 41 showed no improvement in affinity and selectivity at that time. However, several newly synthesized compounds exhibit a
Badiger, J.; et al.
ARKIVOC (Gainesville, FL, United States), 217-217 (2009)
Ferrer, S.; et al.
Tetrahedron, 59, 3445-3445 (2003)
Jing-Ping Liou et al.
Journal of medicinal chemistry, 51(14), 4351-4355 (2008-07-01)
1-Aroylindoline, 1-aroyl-1,2,3,4-tetrahydroquinoline, and 1-aroylindole derivatives were synthesized and evaluated for anticancer activity. The 4-amino and 4-hydroxy-1-aroylindoles 26 and 27 with IC 50 of 0.9 and 0.6 microM, respectively, exhibited antitubulin activity superior or comparable to that of colchicine and combretastatin
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service